HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progesterone receptor action: translating studies in breast cancer models to clinical insights.

Abstract
Progesterone receptors (PR) are useful prognostic indicators of breast cancers likely to respond to anti-estrogen receptor (ER) therapies. However, the role of progesterone, therapeutic progestins, or unliganded or liganded PRin breast cancer development or progression remains controversial. PR are ligand-activated transcription factors that act in concert with intracellular signaling pathways as "sensors" of multiple growth factor inputs to hormonally regulated tissues, such as the breast. The recently defined induction of rapid signaling events upon progestin-binding to PR-B provides a means to ensure that receptors and coregulators are appropriately phosphorylated as part of optimal transcription complexes. PR-activated kinase cascades may provide additional avenues for progestin-regulated gene expression independent of PR nuclear action. Herein, we present an overview ofprogesterone/PR and signaling cross-talk in breast cancer models and discuss the potential significance ofprogestin/PR action in breast cancer biology using examples from both in vitro and in vivo models, as well as limited clinical data. Kinases are emerging as key mediators of PR action. Cross-talk between PR and membrane-initiated signaling events suggests a mechanism for coordinated regulation ofgene subsets by mitogenic stimuli in hormonally responsive normal tissues. Dysregulation of this cross-talk mechanism may contribute to breast cancer biology; further studies are needed to address the potential for targeting PR in addition to ER and selected protein kinases as part of more effective breast cancer therapies.
AuthorsCarol A Lange, Carol A Sartorius, Hany Abdel-Hafiz, Monique A Spillman, Kathryn B Horwitz, Britta M Jacobsen
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 630 Pg. 94-111 ( 2008) ISSN: 0065-2598 [Print] United States
PMID18637487 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)
Chemical References
  • Progesterone Congeners
  • Receptors, Progesterone
  • Progesterone
  • Protein Kinases
Topics
  • Apoptosis (physiology)
  • Breast Neoplasms (pathology)
  • Cell Nucleus (metabolism)
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Models, Biological
  • Neoplasm Invasiveness
  • Phosphorylation
  • Progesterone (pharmacology)
  • Progesterone Congeners (pharmacology)
  • Protein Kinases (metabolism)
  • Receptors, Progesterone (metabolism, physiology)
  • Signal Transduction
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: